CTRI/2019/07/020075
Completed
未知
Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types - Not Applicable
ITC Life Sciences Technology Centre0 sites23 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ITC Life Sciences Technology Centre
- Enrollment
- 23
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.)
- •Subjects representing varied skin types (ideally equal representation of all 4 skin types ââ?¬â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period.
Exclusion Criteria
- •For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
- •(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To understand the safety of investigational products by assessing the irritation after patch application on human volunteers.CTRI/2012/06/002724ITC RD Centre24
Completed
Not Applicable
Safety testing of cosmetic products by patch testCTRI/2017/05/008582ITC Limited ITC Life Sciences Technology Centre35
Completed
Not Applicable
To check the test products safetyCTRI/2024/02/062575Transformative Learning Solutions Pvt Ltd24
Completed
Not Applicable
Safety assessment of products on skiCTRI/2019/03/018068ITC Life Sciences Technology Centre24
Completed
Phase 2
Skin Safety Study on Healthy Human SubjectsCTRI/2017/02/007849Dabur India Limited